Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs
Top Cited Papers
- 1 June 2003
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 2 (6) , 347-356
- https://doi.org/10.1016/s1474-4422(03)00409-5
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Effect of P-Glycoprotein on the Pharmacokinetics and Tissue Distribution of Enaminone Anticonvulsants: Analysis by Population and Physiological ApproachesThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Effect of Felbamate on Clobazam and Its Metabolite Kinetics in Patients With EpilepsyTherapeutic Drug Monitoring, 1999
- In vivoage-related changes in hepatic drug-oxidizing capacity in humansJournal of Clinical Pharmacy & Therapeutics, 1998
- Lack of Interaction of Gabapentin with Carbamazepine or ValproateEpilepsia, 1994
- Vigabatrin‐induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailabilityBritish Journal of Clinical Pharmacology, 1993
- The pharmacokinetics of oxcarbazepine and its active metabolite 10‐hydroxy‐carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acidBritish Journal of Clinical Pharmacology, 1993
- Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugsPharmacology & Therapeutics, 1987
- Complex partial seizures: EEG foci and response to carbamazepine and sodium valproate.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- The effects of phenytoin on phenobarbitone and primidone metabolism.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Effect of sodium valproate on plasma protein binding of diphenylhydantoin.Journal of Neurology, Neurosurgery & Psychiatry, 1977